Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
NovaBay Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing proprietary antimicrobial products, primarily hypochlorous acid-based solutions for eye care, wound care, and dermatology. Its core offerings included Avenova eye spray and wound care products. The company operates in healthcare markets targeting consumers and medical professionals, emphasizing non-toxic, scientifically proven solutions. Currently, it is winding down operations, pursuing liquidation, or exploring strategic alternatives.
This description was generated via AI from an annual report. Updated about 1 year ago.